"What" Series

What types of patent licenses are there?

8 January 2024
2 min read

Patent licenses are divided into the following five basic types:

Type 1, Exclusive license. Within a mutually agreed territory (a country or a region), only the licensee is allowed to implement the patent, and no one else, including the patentee, is allowed to implement the patent.

Type 2: Sole license. Within the agreed territory (a country or a region), only the licensee and the patentee are allowed to enforce the patent, and no third party is allowed to enforce the patent.

Type 3, General License. Within the agreed territory (a country or a region), more than one party may be allowed to enforce the patent.

Type 4, sub-license. In the agreed territory (a country or a region), in allowing the licensee to implement the patent at the same time, also allows the culprit to allow others to implement the patent; this must be specified in the contract, otherwise the licensee sublicense.

Type 5,  cross-license. Negotiated by the two patentees, the two sides unconditional or conditional mutual use of each other's patents.

Sciwind Biosciences Reports Positive Early Results for Long-Acting GLP-1 Analog Ecnoglutide (XW003) in Phase 3 Trial with Chinese Type 2 Diabetes Patients
Latest Hotspot
4 min read
Sciwind Biosciences Reports Positive Early Results for Long-Acting GLP-1 Analog Ecnoglutide (XW003) in Phase 3 Trial with Chinese Type 2 Diabetes Patients
8 January 2024
Sciwind Biosciences Reveals Encouraging Preliminary Outcomes from a Final-Stage Study of Ecnoglutide (XW003), an Extended-Duration GLP-1 Mimetic with Selective cAMP Pathway Activation, in Chinese Adults Suffering from Type 2 Diabetes.
Read →
TPO receptor agonists: What They Are and How to Stay Updated on the Latest Research
TPO receptor agonists: What They Are and How to Stay Updated on the Latest Research
8 January 2024
TPO receptor agonists are drugs that stimulate the thrombopoietin receptor, increasing platelet production.
Read →
Coherus Reveals the Introduction of LOQTORZI™ in the United States Market
Latest Hotspot
4 min read
Coherus Reveals the Introduction of LOQTORZI™ in the United States Market
8 January 2024
Coherus BioSciences, Inc. has recently declared that their product, LOQTORZI™ (toripalimab-tpzi), can now be acquired from certain specialty distribution channels within the U.S. market.
Read →
How many types of patent certifications are available to file an ANDA?
Knowledge Base
2 min read
How many types of patent certifications are available to file an ANDA?
8 January 2024
When submitting an ANDA, generic drug manufacturers need to submit one of the following four statements in accordance with the provisions of the Orange Book.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.